Brief: X4 Pharmaceuticals Announces Restructuring Of Business Operations Designed To Drive Long-Term Value Creation

X4 Pharmaceuticals

17/09/2025 14:13

Sept 17 (Reuters) - X4 Pharmaceuticals Inc XFOR.O:

X4 PHARMACEUTICALS ANNOUNCES RESTRUCTURING OF BUSINESS OPERATIONS DESIGNED TO DRIVE LONG-TERM VALUE CREATION

X4 PHARMACEUTICALS INC - TO CUT WORKFORCE BY 50%, SAVE $13 MILLION ANNUALLY

X4 PHARMACEUTICALS INC - THREE EXECUTIVES TO EXIT X4 PHARMACEUTICALS

X4 PHARMACEUTICALS: AS PART OF WORKFORCE REDUCTION, MARY DIBIASE, CHIEF OPERATING OFFICER WILL BE EXITING CO

X4 PHARMACEUTICALS - JOHN VOLPONE APPOINTED COO IN ADDITION TO CURRENT ROLE AS PRESIDENT

Source text: ID:nGNX7YtVS4

Further company coverage: XFOR.O

 ((Reuters.Briefs@thomsonreuters.com;))